Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2008
08/20/2008CN101244097A Extended release formulation containing acidic active component of gamboge
08/20/2008CN101244068A Hemsleyadin sustained-release preparation
08/20/2008CN101244064A Pharmaceutical combination for preventing and treating motion sickness and preparations thereof
08/20/2008CN101244059A Compound silibinin injection, preparation method and application thereof
08/20/2008CN101244053A Novel dispersed system with docetaxel as main component
08/20/2008CN101244051A Actarit cyclodextrin, clathrate compound of cyclodextrin derivant and preparation thereof
08/20/2008CN101244049A Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof
08/20/2008CN101244045A Zero level drug administration oral administration controlled-release tablet and preparation thereof
08/20/2008CN101244044A Entecavir dispersible tablet and preparation thereof
08/20/2008CN101244043A Bivalirudin freeze-dried injection and preparation thereof
08/20/2008CN101244042A Folic acid freeze-dried injection and preparation thereof
08/20/2008CN101244039A Novel method for preparing indissoluble medicaments liposome preparations
08/20/2008CN101244038A Stable adriablastina lipoid plastid and preparation thereof
08/20/2008CN101244036A High dispersion does type containing cholesterol group phosphoryl nucleoside analogue
08/20/2008CN101244035A Cyclosporins A emulsion preparations for eyes and preparation thereof
08/20/2008CN101244034A Sustained-release agent containing taxone and its synergistic agent
08/20/2008CN101244033A Sustained-release agent containing taxone and its synergistic agent
08/20/2008CN101244031A Bilobalide A injection, preparation method and application thereof
08/20/2008CN101244030A Anticancer sustained-release injection containing estrogen receptor antagon
08/20/2008CN101244029A Anticancer sustained-release injection containing estrogen receptor antagon
08/20/2008CN101244028A System for positioning delivery of medicament and quantitatively controlling and releasing
08/20/2008CN100411688C Medicine composition containing cyclodextrin/polyene taxol and its preparation process
08/20/2008CN100411687C Adhesive patch
08/20/2008CN100411683C Medicinal compositions containing ghrelin
08/20/2008CN100411629C Slow-released type iron-complement agent preparation method
08/20/2008CN100411627C Desensitization face pack for treating facial dermatitis
08/20/2008CN100411626C Preparing method of slow-released type iodine complement agent
08/20/2008CN100411624C Aqueous compositions containing metronidazole
08/20/2008CN100411614C Production of tremella-polysaccharose capsules
08/20/2008CN100411613C Fast releasing solid omeprazole prepn and its preparation process
08/20/2008CN100411612C Quick-disintegration tablets of calcium atovastatine, and its preparation method
08/20/2008CN100411611C Matrix for sustained, invariant and independent release of active compounds
08/20/2008CN100411610C Liposome able to transmit blood and brain screen, medicinal compositions using hiposome as carrier and its preparation method
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/19/2008US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
08/19/2008US7414044 peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide; dye containing a chelated metal, such as hematoporphyrin; aromatic redox compound, such as benzoquinone
08/19/2008US7414038 embolizing agent for arteriovenous aneurysm, which comprises the embolizing material and an appropriate physiologically acceptable water-soluble organic acid
08/19/2008US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
08/19/2008US7413781 Gels for encapsulation of biological materials
08/19/2008US7413751 Methods of treatment using a gastric retained losartan dosage
08/19/2008US7413750 Process for producing solid oral dosage forms with sustained release of active ingredient
08/19/2008US7413742 Clostridial toxin derivatives and methods for treating pain
08/19/2008US7413739 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
08/19/2008US7413727 Contrast agents
08/19/2008US7413538 Epitopes formed by non-covalent association of conjugates
08/19/2008CA2488422C Stable solid medicinal ramosetron composition for oral administration
08/19/2008CA2468708C Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs
08/19/2008CA2421399C Dry-powder film coating composition and method of preparation
08/19/2008CA2396722C Formulations of active components in the form of a solid dispersion
08/19/2008CA2370003C A composition and method for the enhancement of the efficacy of drugs
08/19/2008CA2341732C Powder composition for nasal administration
08/14/2008WO2008098178A2 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
08/14/2008WO2008098151A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
08/14/2008WO2008097317A1 Solvating system and sealant for medical use
08/14/2008WO2008097165A1 Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
08/14/2008WO2008097066A1 An oral sustained-release triple layer tablet
08/14/2008WO2008096904A1 Mannose 6-phosphate-polyethylene glycol conjugate
08/14/2008WO2008096804A1 Eye drop preparation comprising latanoprost
08/14/2008WO2008096779A1 C70-containing liposome, method for producing the same, and use of the same
08/14/2008WO2008096690A1 Polyethylene glycol derivative
08/14/2008WO2008096547A1 Anti-tumor composition comprising tissue-accumulating chitosan gel
08/14/2008WO2008096351A1 Pharmaceutical compositions based on a microemulsion
08/14/2008WO2008096012A2 Multimeric conjugate
08/14/2008WO2008095603A2 Color-marked oligosaccharides or polysaccharides
08/14/2008WO2008095588A1 Composition comprising chitosan and an acidic drug for oral controlled release
08/14/2008WO2008095587A1 Composition comprising covalent conjugates of chitosan and an acidic drug for parenteral administration
08/14/2008WO2008095479A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament
08/14/2008WO2008082721A9 Polymer-stabilized liposomal compositions and methods of use
08/14/2008WO2008065543A3 Modified soluble fgf receptor fc fusions with improved biological activity
08/14/2008WO2008055972A3 N-terminal pegylated prolactin receptor molecules
08/14/2008WO2008045563A9 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates
08/14/2008WO2007110694A3 Gelling hydrophobic injectable polymer compositions
08/14/2008WO2007091250A3 Enzyme replacement therapy for treating lysosomal storage diseases
08/14/2008WO2007055950A3 Polycation-polyanion complexes, compositions and methods of use thereof
08/14/2008WO2006138463A3 Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
08/14/2008US20080194710 Prostatic Stem Cells, Isolation and Uses
08/14/2008US20080194709 Dried Emulsion, Method For Preparing Same and Uses Thereof
08/14/2008US20080194705 water in oil emulsions comprising polyethersiloxane graft polymers, combination with silicone fluids, gums or elastomers and anhydrous polyethers, used as lubricants on the skin
08/14/2008US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia
08/14/2008US20080194676 Formulations for oral administration of cromolyn sodium
08/14/2008US20080194663 Novel sustained release polymer
08/14/2008US20080194612 Water soluble ; polymer joining active materials; antitumor agents
08/14/2008US20080194540 Desipramine, imipramine, trimipramine, amitriptyline, nortriptyline, doxepin, amoxapine, or maprotyline and chloroquine, promazine, quinine, biquinoline, phenothiazine or chlorpromazine; transfection or gene therapy
08/14/2008US20080194532 Ophthalmic or cosmetic oil-in-water emulsions containing a cetylalkylammonium halide, a vegetable oil, a surfactant and one of riluzole, fusidic acid, latanoprost, loratadine, tacrolimus, naphazoline or ketanserin; nontoxic
08/14/2008US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
08/14/2008US20080194500 Preferably polyethylene glycol etherified by an aliphatic alcohol and a perfluorodiol attached to a di-stearoyl glycerophosphatidylethanolamine; improved water solubility and decreased toxicity of paclitaxel, rapamycin, geldanamycin, doxorubicin, or amphotericin B
08/14/2008US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug
08/14/2008US20080193762 Water soluble metal and semiconductor nanoparticle complexes
08/14/2008US20080193545 Use of Glycerol Dipalmitostearate for Improving the Bioavailability of Protein Active Ingredients in Subcutaneous or Intramuscular Injectable Formulations
08/14/2008US20080193541 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases
08/14/2008US20080193540 Solid, Oral Drug Form Which Has Been Designed to Prevent Misuse
08/14/2008US20080193539 Novel Stabilized Carotenoid Compositions
08/14/2008US20080193523 Composition
08/14/2008US20080193519 An efflux pump inhibitor (2S)-2-(naphthyl-1-sulphonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid or the ethyl ester and a surfactant; improved intestinal absorption when orally administered
08/14/2008US20080193509 Liposome Preparation Containing Slightly Water-Soluble Camptothecin
08/14/2008US20080193505 Nutritional Compositions For Modulating Vitamin C Bio-Availability
08/14/2008US20080193490 Use of Carbon Nanotube for Drug Delivery
08/14/2008US20080193481 Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines
08/14/2008US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
08/14/2008US20080193425 Methods for administering fgf18
1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 1712